SCHEMBL904735

SCHEMBL904735

Cc1cc(Br)ccc1S(=O)(=O)NCc1ccc2c(cnn2C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
KMT2A Q03164 8/20 0.43
MEN1 O00255 7/20 0.43
ALDH1A1 P00352 6/20 0.43
MAPT P10636 6/20 0.43
RECQL P46063 4/20 0.43
POLB P06746 3/20 0.43
GAA P10253 1/20 0.43
S100A4 P26447 1/20 0.43
THRB P10828 5/20 0.42
NPC1 O15118 1/20 0.41
NR2F2 P24468 1/20 0.41
NOD2 Q9HC29 1/20 0.41
BAZ2B Q9UIF8 1/20 0.41
RAB9A P51151 1/20 0.40
LMNA P02545 1/20 0.39
BRD4 O60885 1/20 0.39
BRD1 O95696 1/20 0.39
BRPF1 P55201 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL904599 0.88 LMNA (0.41) KMT2AMEN1ALDH1A1MAPTRECQL
SCHEMBL904754 0.88 CA1 (0.42) CA1CA2KMT2AMEN1ALDH1A1
SCHEMBL904700 0.85 CA1 (0.42) CA1CA2KMT2AMEN1ALDH1A1
SCHEMBL904733 0.83 PDE1C (0.43) KMT2AMEN1ALDH1A1MAPTRECQL
SCHEMBL904680 0.82 CA1 (0.47) CA1CA2KMT2AMEN1ALDH1A1
SCHEMBL25213780 0.78 ALDH1A1 (0.68) KMT2AMEN1ALDH1A1MAPTRECQL
SCHEMBL25220708 0.75 ALDH1A1 (0.56) KMT2AMEN1ALDH1A1MAPTRECQL
SCHEMBL904717 0.74 MAOA (0.43) ALDH1A1MAPTRECQLPOLBTHRB
SCHEMBL904760 0.74 POLB (0.41) KMT2AMEN1ALDH1A1MAPTRECQL
SCHEMBL120177 0.73 LMNA (0.66) CA1CA2KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8829026-B2 Sulfamoyl benzoic acid heterobicyclic derivatives as TRPM8 antagonists RAQUALIA PHARMA INC. (JP) 2014-09-09 US disclosed
US-20130210858-A1 SULFAMOYL BENZOIC ACID HETEROBICYCLIC DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2013-08-15 US disclosed
WO-2012042915-A1 SULFAMOYL BENZOIC ACID HETEROBICYCLIC DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210858-A1 SULFAMOYL BENZOIC ACID HETEROBICYCLIC DERIVATIVES AS TRPM8 ANTAGONISTS TRPM8, TRPM6, TRPM5 CA1 868/4885CA2 197/4885KMT2A 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.